2021 Archives -

It has been five years since the first biosimilar launched in the United States market—marking the first steps

The US biosimilar market: Predictions for 2021

https://pharmaphorum.com/views-and-analysis/biosimilar-market-predictions-2021/

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are

What we’re expecting in 2021, and beyond…

https://pharmaphorum.com/digital/digital-health-trends-predictions-2021/

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a

Clinical research in 2021: A new era of collaboration and innovation

https://pharmaphorum.com/r-d/views-analysis-r-d/clinical-research-in-2021-a-new-era-of-collaboration-and-innovation/

In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact

Nine for 2021: Addressing the pandemic legacy

https://pharmaphorum.com/views-analysis-sales-marketing/nine-for-2021-pandemic-legacy/

Everything, from exercise classes to pub quizzes, went online last year – and medical education was no exception.

Are face-to-face medical meetings a thing of the past?

https://pharmaphorum.com/views-and-analysis/are-face-to-face-medical-meetings-a-thing-of-the-past/

2020 was the year that changed everything, and as the new year begins many are wondering what awaits

2021 – The healthcare changes here to stay

https://pharmaphorum.com/views-analysis-digital/2021-healthcare-change/

In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that

Nine for 2021: The COVID-19 legacy

https://pharmaphorum.com/views-and-analysis/nine-for-2021-the-covid-19-legacy/

The pandemic has shed light on inefficiencies in healthcare systems, and provided an opportunity to adjust how we

How Big Data will accelerate the future of digital medicine in 2021

https://pharmaphorum.com/views-analysis-digital/the-future-of-digital-medicine-in-2021/

2021